Quantifying human susceptibility to contact sensitization; risk assessments now and in the future
Quantifying human susceptibility to contact sensitization; risk assessments now and in the future
Assessment and quantification of the risk that a chemical will induce allergic contact sensitization presently depend heavily on background data from animal tests. Following the banning of animal testing of chemicals used in cosmetics and personal products in Europe after 2013, alternative approaches will be required. The chemical properties likely to make a given compound a sensitizer can be determined in vitro with reasonable certainty, but confirmation that it is a sensitizer comes only from in vivo exposure to it. Assessment of the sensitization risks involves consideration of how much of the compound will be applied to skin, for how long, and at which sites. However, the in vivo interactions of the chemical with the skin, with regard to its permeability, and biochemical and immune defences, cannot be predicted from a theoretical position. The xenobiotic-metabolizing enzymes and antioxidant defences may degrade chemicals or may generate potentially immunogenic haptens. Many factors can modify the skin and the immune response, including sex, race, age, genetic programming of epidermal permeability, and/or antioxidant and drug-metabolizing pathways. The only certain way to evaluate whether a chemical will sensitize is in vivo exposure, and the nature of the hazard is revealed by determination of the dose-response relationship. This review shows there is still a serious gap in our understanding of the biological factors and variables involved in conferring resistance or susceptibility to the development of allergic sensitization by chemicals. We are not yet in a position to predict sensitization by chemicals from a theoretical starting point.
contact sensitization, dncb, epidermal barrier, quantitative risk assessment, stratum corneum, review
237-247
Friedmann, Peter S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
Pickard, Christopher
4d8b8c85-8118-4a54-b737-360344ab6e40
November 2010
Friedmann, Peter S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
Pickard, Christopher
4d8b8c85-8118-4a54-b737-360344ab6e40
Abstract
Assessment and quantification of the risk that a chemical will induce allergic contact sensitization presently depend heavily on background data from animal tests. Following the banning of animal testing of chemicals used in cosmetics and personal products in Europe after 2013, alternative approaches will be required. The chemical properties likely to make a given compound a sensitizer can be determined in vitro with reasonable certainty, but confirmation that it is a sensitizer comes only from in vivo exposure to it. Assessment of the sensitization risks involves consideration of how much of the compound will be applied to skin, for how long, and at which sites. However, the in vivo interactions of the chemical with the skin, with regard to its permeability, and biochemical and immune defences, cannot be predicted from a theoretical position. The xenobiotic-metabolizing enzymes and antioxidant defences may degrade chemicals or may generate potentially immunogenic haptens. Many factors can modify the skin and the immune response, including sex, race, age, genetic programming of epidermal permeability, and/or antioxidant and drug-metabolizing pathways. The only certain way to evaluate whether a chemical will sensitize is in vivo exposure, and the nature of the hazard is revealed by determination of the dose-response relationship. This review shows there is still a serious gap in our understanding of the biological factors and variables involved in conferring resistance or susceptibility to the development of allergic sensitization by chemicals. We are not yet in a position to predict sensitization by chemicals from a theoretical starting point.
This record has no associated files available for download.
More information
Published date: November 2010
Keywords:
contact sensitization, dncb, epidermal barrier, quantitative risk assessment, stratum corneum, review
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 195515
URI: http://eprints.soton.ac.uk/id/eprint/195515
ISSN: 0105-1873
PURE UUID: 4e95d327-45ce-4b29-b981-f1dad1e75a64
Catalogue record
Date deposited: 22 Aug 2011 15:27
Last modified: 14 Mar 2024 04:04
Export record
Altmetrics
Contributors
Author:
Peter S. Friedmann
Author:
Christopher Pickard
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics